Functionalization of the TMEM175 p.M393T variant as a risk factor for Parkinson disease

Abstract Multiple genome-wide association studies (GWAS) in Parkinson disease (PD) have identified a signal at chromosome 4p16.3; however, the causal variant has not been established for this locus. Deep investigation of the region resulted in one identified variant, the rs34311866 missense SNP (p.M...

Full description

Saved in:
Bibliographic Details
Published inHuman molecular genetics Vol. 28; no. 19; pp. 3244 - 3254
Main Authors Jinn, Sarah, Blauwendraat, Cornelis, Toolan, Dawn, Gretzula, Cheryl A, Drolet, Robert E, Smith, Sean, Nalls, Mike A, Marcus, Jacob, Singleton, Andrew B, Stone, David J
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.10.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Multiple genome-wide association studies (GWAS) in Parkinson disease (PD) have identified a signal at chromosome 4p16.3; however, the causal variant has not been established for this locus. Deep investigation of the region resulted in one identified variant, the rs34311866 missense SNP (p.M393T) in TMEM175, which is 20 orders of magnitude more significant than any other SNP in the region. Because TMEM175 is a lysosomal gene that has been shown to influence α-synuclein phosphorylation and autophagy, the p.M393T variant is an attractive candidate, and we have examined its effect on TMEM175 protein and PD-related biology. After knocking down each of the genes located under the GWAS peak via multiple shRNAs, only TMEM175 was found to consistently influence accumulation of phosphorylated α-synuclein (p-α-syn). Examination of the p.M393T variant showed effects on TMEM175 function that were intermediate between the wild-type (WT) and knockout phenotypes, with reduced regulation of lysosomal pH in response to starvation and minor changes in clearance of autophagy substrates, reduced lysosomal localization, and increased accumulation of p-α-syn. Finally, overexpression of WT TMEM175 protein reduced p-α-syn, while overexpression of the p.M393T variant resulted in no change in α-synuclein phosphorylation. These results suggest that the main signal in the chromosome 4p16.3 PD risk locus is driven by the TMEM175 p.M393T variant. Modulation of TMEM175 may impact α-synuclein biology and therefore may be a rational therapeutic strategy for PD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Present address: Cerevel Therapeutics, LLC, 131 Dartmouth Street. Suite 502, Boston, MA 02116, USA.
ISSN:0964-6906
1460-2083
1460-2083
DOI:10.1093/hmg/ddz136